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Summary 
Influenza epidemics and pandemics resulting in excess mortality are due 
to various Influenza viruses, in which through the accumulation of muta- 
tions the structure changes. A world-wide surveillance has been set up 
for early detection of new influenza virus strains and of epidemics or 
pandemics resulting thereof. Basing on such data the World Health 
Organisation (WHO) issues recommendations to Public Health authori- 
ties on the most efficient means for prevention. 
Characteristics of the virus 
A number of epidemics caused by 
influenza has been described in 
historical times. Hippocrates re- 
ported in 412 BC about such an 
epidemic. Later on, it was observed 
that outbreaks occurred frequently 
but at irregular intervals. Historical 
data were reviewed by Noble and 
in his review, several characteristics 
of influenza epidemics and pande- 
mics were pointed out: 1. They ap- 
pear at irregular intervals; 2. They 
vary in severity and they usually 
cause mortality in the elderly; 3. The 
epidemics often come from Asia. 
The virus shows some peculiar 
properties which allows it to cause 
epidemics under certain condi- 
tions. Subsequently some charac- 
teristics will be summarized, in 
order to better understand this 
phenomenon. 
Nomenclature 
Influenza A and B viruses belong 
to the family of the Orthomyxovi- 
ruses. They can be distinguished 
from each other by differences in 
certain proteins like nucleopro- 
teins and matrix proteins. Influenza 
viruses are highly variable. There- 
fore, a system had to be established 
to be able to distinguish the vari- 
ants from each other. The current 
system includes the host of origin, 
geographical location of the first 
isolation, strain number, and year 
of isolation. The description of the 
types of surface proteins is given in 
parenthesis. To give an example: 
A/Swine/Iowa/15/30(H1N1) 
This represents an influenza A 
virus which has been isolated from 
a swine in 1930 in Iowa. It was the 
15 th isolate of that particular year. 
H 1 and N1 are the types of the two 
surface proteins present in this 
virus. The host is not indicated if
the virus strain detected is of 
human origin. As we will see in the 
following it is very important o 
distinguish the different variants in 
particular for the production of 
vaccines. 
Structure of the virus 
Electron microscopy shows influ- 
enza viruses as spherical, irregular- 
ly shaped, with a diameter of about 
120 nm. The virus constitutes a
lipid bilayer, containing the typical 
surface glycoproteins hemagglu- 
tinin (HA) and neuraminidase 
(NA) (Fig. 1). These proteins form 
a layer of spikes projecting radially 
outward. Three types of HA (H1, 
H2, H3) and two types of NA (N1, 
N2) are found in viruses which can 
infect humans. These two surface 
proteins are essential for the pro- 
cess of infection and virus release. 
Normally, these proteins are detect- 
able on the surface of infected cells, 
before the virus buds through the 
membrane, taking a piece of the 
lipid bilayer as an envelope contain- 
ing the two surface proteins. 
In cells infected in vitro, the viral 
hemagglutinin can be detected on 
the cell surface by a specific labeled 
antibody (Fig. 2 a) before the virus 
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Figure 1. Influenza virus (schematic 
representation). 
is released. A vertical cut through 
the cell layer shows that the viral 
protein can be detected on the sur- 
face of the cell (Fig. 2 a, lower part). 
This is also the case in vivo. 
Within the lipid envelope, there is 
the matrix protein, containing eight 
single-stranded RNA molecules. 
The segmentation of the viral 
genome is an important feature by 
which the virus can modify its sur- 
face. 
Nature of the antigenic drift 
and antigenic shift 
As described, the virus needs the 
two surface glycoproteins to infect 
efficiently its host cell. But how 
does the virus manage to change 
the structure of the proteins 
without loosing its infectivity? 
Different mechanisms have been 
found. One is the so called antigen- 
ic drift. Through the accumulation 
of point mutations in certain regi- 
ons of the genome coding for the 
hemagglutinin, amino acid substi- 
tutions can occur. Through the 
accumulation of such mutations, 
the protein can gradually change its 
structure over time. In other words, 
antibodies which were formed 
(A) (B) 
Figure 2. MDCK cells infected with influenza A/PR/8/34(HTN~) virus. Con- 
focal laser scanning microscopy icture taken 23 h after infection. (A) The 
structural protein actin is labeled with fluorescent phalloidin to show the 
morphology of the MDCK cells. (B) The same area as in (A) is shown with 
fluorescently labeled hemagglutinin (antibody labeling). The hemagglutinin 
appears in the perinuclear area nd at the cell surface of infected cells. 
against an older variant of the virus 
will not be able to bind or bind less 
efficiently to the surface proteins of 
a new variant. Neuraminidase is
the second spike protein of the 
virus. The gene which codes for the 
neuraminidase is also subjected to 
an antigenic drift, and it is believed 
that the nature of the changing 
mechanism is the same. Through 
the follow up of virus strains over 
time, one can see that antibodies 
formed against older strains will 
gradually become inefficient. This 
is one of the reasons why the com- 
position of the vaccine has to be 
adapted continuously. 
Another much more drastic hange 
was discovered. Strains with such 
principal changes were much more 
pathogenic, and under certain con- 
ditions severe pandemics occurred. 
Analysis of strains causing pan- 
demics showed that much more 
substantial changes could be detect- 
ed. Against these strains, apparent- 
ly little or no herd immunity exis- 
ted and this was the reason for the 
rapid and efficient ransmission i  
the population. But what is the 
mechanism? Theoretically it is pos- 
sible that a host is infected with two 
different virus strains. Under such 
conditions, and because the genome 
segments are not linked together, it
is possible that the segments of 
the two distinct strains are mixed 
and arbitrarily distributed into the 
virus progeny. Therefore, the sur- 
face proteins can be coded from 
genomes coming from the two 
parent strains. Under what condi- 
tions can such a drastic change 
occur? As we know, there is a large 
reservoir of animal influenza viruses 
with different properties, in partic- 
ular viruses isolated from birds. 
However these strains can not 
directly infect humans. An ex- 
change of a genome is only think- 
able if there is a common host. That 
means a host must exist which can 
be infected with both types of 
viruses. The only situation known 
today is in swine. These animals 
can be infected with both types of 
viruses, namely from humans and 
from aquatic birdsL After a mixed 
infection in swine and the exchange 
of genomes, certain modified vari- 
ants arise which will be able to 
infect humans again. A pandemic 
can arise due to the lack of im- 
munity against such a variant in the 
population. Apparently this type of 
event is rare and unpredictable, as 
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Year when a 
pandemic occurred 
Subtype of the 
influenza A viruses 
Severity :of 
the pandemic 
1918 HI N, devastating: 
1957 H2N 2 severe 
1968 H3N~ moderate 
1977 H~N~ mild 
Table 1. Characteristics of pandemics in our century caused by influenza A. 
we can see from the frequency of 
pandemics which occurred in our 
century (Table 1). 
Under certain conditions, additio- 
nal mechanisms can occur which 
allow the exchange of only a part of 
a genome (crossing-over). Through 
this mechanism the virus can ac- 
quire some hidden changes and 
may cause pandemics which will 
not have the same degree of sever- 
ity as it would be with a strain with 
a totally new surface protein. 
Analysis of the different strains 
which caused pandemics in our 
century showed that every time one 
or two of the two surface proteins 
were completely changed, a pan- 
demic occurred (Table 1). However 
they occurred at irregular intervals. 
Consequences of epidemics 
and pandemics 
Due to the characteristics of the 
virus there is a continuous threat of 
another pandemic. Is it worth to 
worry about such widespread in- 
fections? In fact the well known 
"Spanish Influenza" from 1918 cau- 
sed more than 20 million deaths 1. 
However, one can observe an excess 
of mortality not only during pande- 
mics but also during epidemics 3.
For example in the USA, there were 
70000 estimated deaths in 1957 
(caused by the Asian influenza) and 
30 000 in 1968 (caused by the Hong 
Kong virus 2). 
Not only the consequences of a 
pandemic are impressive but also 
those of an epidemic are consider- 
able. Influenza infects all age 
groups and the age specific inci- 
dence rate is highest in children 
between one and 14 years. Even if 
the incidence rate in people older 
than 60 years 2 is smaller, the hos- 
pitalization rates are highest in 
the _> 65 and also for the very young 
(< five years). The death rate is 
low in children (2.7 per 100000) 
and considerably higher 2 in the 60 
years or older (75.9 per 100 000). 
This shows that besides virological 
aspects, the consequences of an 
infection justify a world-wide sur- 
veillance. Therefore, WHO estab- 
lished a system for the surveillance 
of the influence virus activity. 
System of influenza surveillance 
In 1947, a group of experts recom- 
mended to create an international 
center for the collection of infor- 
mation about influenza nd for the 
coordination of the laboratory 
work. The task was given to the 
National Institute of Medical Re- 
search in Mill Hill. Since then the 
system has been developed and 
modified, so that the surveillance 
of influenza can cover the whole 
world. 
Today, the system is based on three 
different components (Table 2). 
- Nat iona l  centers :  Each country 
organizes the surveillance of in- 
fluenza activity in its area. But the 
financing of the surveillance is up 
to the government. Because not all 
the countries can afford special- 
ized laboratories, the surveillance 
can not be done everywhere in the 
same way. The principal aim is to 
try virus isolations and a pre- 
liminary characterization of the 
isolates. Through this comparison, 
S 
WHO 
logistic tasks of surveillance and 
analysis of the actual situation 
REFERENCE CENTERS 
1. National Institute of Medical Research, Mill Hill 
2. CDC, Atlanta 
3. Commonwealth Serum Laboratories, Melbourne 
NATIONAL CENTERS 
109 laboratories from 79 countries: 
Surveillance of influenza activity in countries 
Table 2. System for the world-wide surveillance of influenza. 
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already on the national level, 
important information can be 
obtained about the frequency of 
strains in certain regions and coun- 
tries and also about the pathogeni- 
city of variants. 
The results of influenza surveil- 
lance and the type of strains de- 
tected are transmitted regularly to 
WHO in Geneva. A selection of 
virus strains is sent to one of the 
three reference centers for an 
extended analysis. National centers 
often collect more additional data 
about the epidemiology of an 
influenza season or an outbreak. 
These parameters (morbidity, mor- 
tality, frequency of consultations 
for respiratory disease, etc.) are 
also transmitted to WHO. 
-Re ference  centers have mainly 
virological tasks. By extended ana- 
lysis they compare and character- 
ize virus strains ent by the national 
centers. Beside the classical me- 
thods of comparison, they also use 
characterization techniques by 
monoclonal antibodies or by geno- 
mic analysis. 
They also produce reagents for the 
national centers o that they can do 
a first characterization. Reference 
centers also work out scientific and 
technical recommendations for 
WHO and for the centers. 
- WHO is mainly responsible for 
the logistic task of the surveillance, 
as well as the coordination of the 
exchange of information. Today, 
not only is the publication of 
data a major task but a regular 
update of an Internet home page 
with the latest epidemiological 
data has become an important 
source of information (address: 
http://www.who.ch). 
On the basis of the epidemiological 
results, WHO, together with ex- 
perts works out the composition of 
the vaccine for the next season. 
Only so the vaccine can stay an effi- 
cient means for prevention. 
In case of a pandemic, WHO ac- 
tivates a task force, which will con- 
tinuously analyze the situation and 
which will give recommendations 
for the governments. 
In Europe, there exists some sort of 
suborganization. The major aim of 
this structure is a rapid exchange of 
information. The organization is in 
part associated with the govern- 
ment on one side (public health 
authorities) and on the other side 
with the vaccine producing indu- 
stry. Through this, an active 
exchange of information among 
the countries is possible. Switzer- 
land is also participating in this 
European system. 
Aims of influenza surveillance 
The organization of a world wide 
influenza surveillance system is an 
expensive and rather complicated 
task. Not all the countries will have 
the necessary resources to build up 
an appropriate surveillance system. 
Because of different limitations 
and restrictions, urveillance is not 
done by a standardized system and 
it is a tricky task for WHO to coor- 
dinate such a system and to make a 
synthesis of the results. Neverthe- 
less it is essential to define what 
type of information one would like 
to obtain. Only then can the limited 
resources be used in an optimal 
way. 
Normally, surveillance should be 
done all year round. But most of 
the national centers can only afford 
to do it during the time where 
influenza is most prevalent (in the 
winter of the corresponding hemi- 
sphere). For the northern hemi- 
sphere, surveillance is normal- 
ly done between November and 
April, and in the southern hemi- 
sphere between April and October. 
Seasonal differences are less pro- 
nounced in tropial and subtropi- 
cal areas. Influenza is circulating 
there all year round but at a lower 
frequency. Because of the con- 
tinuous circulation of the virus it 
would be ideal to do surveillance 
all year round. 
What is the information one can 
obtain from such a system? They 
are summarized as follows: 
- Detection o f  epidemics orpande-  
mics 
Outbreaks caused by influenza 
should be detected as early as pos- 
sible. Also the strain or the variant 
causing the outbreak should be 
identified very rapidly. With this 
information the severity of an out- 
break can be estimated and further 
recommendations can be given. 
- Properties o f  the virus 
It may not be evident hat the cha- 
racteristics of a virus causing epide- 
mics is crucial. For several reasons 
however, a new variant must be 
identified and characterized asear- 
ly as possible: 
- Only when the virological pro- 
perties of the virus strain are 
known can other epidemiological 
questions be answered properly. 
- O n e  must know whether the 
strain used for the vaccine is 
sufficiently related to the new 
variant. Only then one can know 
whether the actual vaccine is still 
efficient. 
- If the strain is too different (shift), 
the production of a new vaccine 
has to be envisaged (monovalent 
vaccine). The production of a new 
vaccine can take several months. 
The decision whether a new virus 
has the potential to cause a pande- 
mic will never be an easy task. 
- Epidemiological  details about a 
particular outbreak 
- An important information about 
an outbreak will be whether partic- 
ular age groups are concerned by 
the infection and if a pronounc- 
ed influence on the mortality is 
observed. 
- One must know if there is a par- 
ticular group of persons or patients 
at high risk due to particularities of
the virus. 
- Also from virological data, one 
can conclude whether vaccinated 
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persons are more or less protected 
against he virus. 
- Collection of additional informa- 
tion about the epidemics like speed 
of outspread, centers of infection 
and in which countries the strain is 
most prevalent. 
- Precautions for prevention 
With all the data obtained from the 
surveillance, WHO will be able to 
give recommendations to health 
authorities how to achieve the most 
efficient prevention. 
In general, a global surveillance of 
the influenza activity has for its 
major goal to gain time for preven- 
tion. Only then can the morbidity, 
the rates of hospitalization, the 
mortality and the costs be control- 
led in case of an outbreak or a pan- 
demic. 
. . . . . . . .  = Zusammenfassung = = 
Weltweite Oberwachung der Grippe 
Influenza fpidemien odor Pandemien, die zueiner erhOhten Sterbtichkeit 
fOhren; worded:dutch verschiedene Influehzawiren verursacht, deren 
Struktur sich durch die geh~uften Mutationen ver~nde# hat. Um die 
frOhe Erkennung yon neuen Influenza4VirusStammen zu gew~hrleisten 
und um die Ge~hr allf~lliger Epidemien odor Pandemien Zu reduzieren, 
besteht ein weltweites O~)erwaehungsne~i D e Weitgesundhei~organF 
sation WHO ver6ffentticht, gest#tzt auf die durch die Uberwachung 
:gewonnenen Daten,:Empfehiunge# Ober Massnahmen zu~ bestm6gfi- 
Chen und effizientesten Pravention. 
Resumd 
Surveillance mondiale d'influenza 
es epld~mles et los pand~mtes:d influenza qu~ condulsent a une mor- 
talit~ accrue sent provoqu~es pa~ divers virus de t'influenza, dent la 
structure a ~t~ modifi~e par I accumulation de mutations. Un rOseau de 
surveillance mondial a ~te mis sur pied pour assurer la d~tection pr~vue 
de nouvelles souches du virus de:l'influenza et pour r~duire le danger 
d'~pidemie ou de pand~mie. En se basant sur los resultats de: cette 
surveillance I'Organistion Mondiale de la Santo (OMS) publie des recom- 
mandations ur los rnesures b prendre pour une pr~ventlon aussi efficace 
que possible. 
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